Bristol-Myers introduced BICNU (carmustine), for treatment of brain and lymphatic cancers

In 1977, Bristol-Myers introduced BICNU (carmustine), for treatment of brain and lymphatic cancers.

Tags:


Source: Bristol-Myers Squibb Company
Credit: